CO-CSG
23.1.2024 14:31:29 CET | Business Wire | Press release
Communication service providers (CSPs) are racing to modernize their operations and deliver dynamic and personalized experiences for their customers. To leverage automation, intelligence and orchestration, they’re working to improve the customer experience across all touchpoints. In 2023, CSG® (NASDAQ: CSGS)’s award-winning solutions and integrated omnichannel approach helped global brands transform their customer experience, earning CSG recognition from leading analyst firms Gartner, Frost & Sullivan, Kaleido Intelligence, MGI and Quadrant Knowledge Solutions.
In recent months, CSG has been recognized as:
-
A Niche player in the 2023 Gartner® Magic Quadrant™ for Configure, Price and Quote Application Suites
- CSG Quote & Order enables CSPs to configure products with live pricing, creating comprehensive orders that seamlessly flow from quotes to fulfillment. An API-powered CPQ solution built for complex B2B services, it provides CSPs with the composability and order management capabilities they need to drive faster time to revenue and deliver a better overall customer experience.
-
A Leader in the 2023 Frost Radar for 5G Revenue Management and Monetization
- CSG enables CSPs to reduce reliance on multi-vendor solutions, lowering time to market and total cost of ownership by integrating charging, billing, policy control and interconnect. The depth of its capability portfolio, modular SaaS platforms and unique partnership-driven approach earn CSG a leadership placement for its ability to monetize a variety of 5G use cases on a single SaaS platform.
- Frost & Sullivan writes: "CSG has proven how it can integrate assets from a network and a messaging portfolio to provide a one-stop shop for CSPs. The company has mastered the challenges of hybrid operations."
-
A Leader in the 2023 MGI 360 Rating: The Agile Billing Top 50 Buyers Guide
- MGI recognized CSG Ascendon as “a good fit for organizations looking to create modern monetization capability to support new business initiatives”. The report states: "CSG Ascendon represents a multi-tenant SaaS approach to monetization tools for B2C-oriented digital services. It has a sophisticated product catalog capability, can support customer and product hierarchies and abstract complex pricing methods, including usage."
-
A Champion in the 2023 Kaleido Intelligence Roaming Vendor Hub – Clearing & Settlement
- CSG Retail Roaming Management platform enables CSPs to build new dynamic digital wholesale services and to drive the associated business models over 4G and 5G networks of any size. Kaleido notes: The CSG platform is "agile and extensible, bringing significant new functionality with minimal disruption to existing infrastructure."
- CSG was also recognized as a High-Flyer in the Roaming Analytics & VAS and Fraud Management rating categories.
-
A Leader in the 2023 SPARK Matrix: Configure, Price & Quote
- CSG Quote & Order helps service providers deliver complex digital offerings by addressing the dual challenges of B2B2X relationships with customers and partners. Its comprehensive capabilities, impressive customer references, well-defined roadmap and vision and a highly scalable product suit earn CSG strong ratings for technological excellence and customer impact.
- Quadrant Knowledge Solutions notes: "CSG offers a leading CPQ portfolio, customized specifically for the telecom industry, apart from also having strong third-party partnerships, robust functional capabilities and an extensive customer base."
Beyond these recognitions, CSG is mentioned in the 2023 Gartner Market Guide for CSP Customer Management and Experience Solutions, which CIOs can use to shape their sourcing strategy by understanding the investments and directions of representative vendors. CSG was also mentioned in the 2022 Gartner Market Guide for Revenue Management and Monetization as one of 20 vendors providing a wide variety of solutions, offering different portfolios, deployment/implementation approaches and focus areas for various segments of CSPs.
“Global operators trust CSG to modernize their business because we've demonstrated time and again that we understand their customers’ needs and provide the capabilities they need to drive tangible growth,” said Chad Dunavant, Chief Product & Strategy Officer, CSG. “The breadth and depth of our portfolio support CSPs regardless of their focus on B2C, B2B or B2B2X as we empower them to deliver new services faster than competitors, increase customer satisfaction and boost brand loyalty. This has been our bread and butter for 40+ years and is why industry analysts consistently rank CSG among the leading BSS solution providers across the industry.”
For more information about CSG, visit www.csgi.com.
Gartner, Magic Quadrant for Configure, Price and Quote Application Suites, Mark Lewis, Dayna Radbill, 11 December 2023.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
Gartner and Magic Quadrant are registered trademarks of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.
About CSG
CSG empowers companies to build unforgettable experiences, making it easier for people and businesses to connect with, use and pay for the services they value most. Our customer experience, billing and payments solutions help companies of any size make money and make a difference. With our SaaS solutions, company leaders can take control of their future and tap into guidance along the way from our fiercely committed and forward-thinking CSGers around the world.
Want to be future-ready and a change-maker like the global brands that trust CSG? Visit csgi.com to learn more.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240123732657/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
